IntelGenx (TSXV:IGX; OTCQX:IGXT) reported on progress in its cannabis-infused VersaFilm product co-development program with partner, Tilray (NASDAQ:TLRY).
“We are currently conducting scale-up activities for an anticipated commercial launch,” Dr. Horst Zerbe, CEO of IntelGenx, said in a statement.
“With the recent Cannabis Act amendments authorizing the sale of new classes of cannabis products, including oral films, we are well-positioned participate in the expanded cannabis market just as new product formats come online,” he added.
The company plans to unveil product details closer to commercial launch.
